Observational × Thromboembolism × Lymphoid × Clear all
NCT03098589 2025-03-30

Revlimid® Capsules Drug Use-results Surveillance (Relapsed or Refractory ATLL)

Celgene

Completed
1,149 enrolled
NCT03099031 2019-12-16

PREDICARE

LEO Pharma

Completed
420 enrolled